Literature DB >> 10206994

A pivotal role for the transmembrane domain in transforming growth factor-beta receptor activation.

H J Zhu1, A M Sizeland.   

Abstract

Transforming growth factor-beta (TGF-beta) delivers diverse growth and differentiation signals by binding two distantly related transmembrane serine/threonine kinase receptors: the type I receptor (TbetaRI) and the type II receptor (TbetaRII). In an attempt to establish the role of the transmembrane domain in receptor signaling, two chimeric TGF-beta receptors, TbetaRI-II-I and TbetaRII-I-II, containing the opposite transmembrane domain were generated. When transfected into a mutant mink lung epithelial cell line R1B, which lacks functional TbetaRI, TbetaRI-II-I restored TGF-beta1-induced transcriptional activation of a TGF-beta reporter p3TP-Lux to approximately 25% of the levels restored by wild-type TbetaRI. In the mutant mink lung epithelial cell line DR26, which contains a truncated, nonfunctional TbetaRII, wild-type receptor TbetaRII restored the TGF-beta responsiveness, while the TbetaRII-I-II cDNA was inactive. When both TbetaRI and TbetaRII were transfected into R1B, DR26, or Mv1Lu cells, a low level of constitutive p3TP-Lux activity was observed. However, cotransfection of both transmembrane chimeric receptors, TbetaRI-II-I and TbetaRII-I-II, or the wild-type TbetaRI with the transmembrane chimeric TbetaRII-I-II resulted in high levels of ligand-independent receptor activation. These results suggest that the transmembrane domains of both TGF-beta receptors are essential and play a pivotal role in receptor activation. To investigate the role of the transmembrane domain further, four type II transmembrane mutants were generated: TbetaRIIDelta-1, TbetaRIIDelta-2, TbetaRIIDelta-3, and TbetaRIIDelta-4, which have one, two, three, or four amino acids deleted at the N terminus of the transmembrane domain, respectively. Interestingly, co-expression of TbetaRIIDelta-1 with the wild-type TbetaRI in DR26 cells resulted in high levels of constitutive activation, while only low levels of the activation were observed when TbetaRIIDelta-2, TbetaRIIDelta-3, or TbetaRIIDelta-4 were co-expressed with the wild-type TbetaRI. However, TbetaRIIDelta-1 restored very little the TGF-beta responsiveness in DR26cells. Expression of TbetaRIIDelta-2, TbetaRIIDelta-3, and TbetaRIIDelta-4 resulted in a progressive increase in TGF-beta responsiveness, with TbetaRIIDelta-4 reaching the level of activity of the wild-type TbetaRII. Furthermore, like TbetaRII-I-II, co-expression of TbetaRIIDelta-1 with TbetaRI-II-I also resulted in high levels of constitutive activation. These results are consistent with an important role for the transmembrane region of the receptors. We further propose a model of receptor activation in which receptor activation occurs via relative orientational rotation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10206994     DOI: 10.1074/jbc.274.17.11773

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Structural requirements of the interleukin-6 signal transducer gp130 for its interaction with Janus kinase 1: the receptor is crucial for kinase activation.

Authors:  Claude Haan; Peter C Heinrich; Iris Behrmann
Journal:  Biochem J       Date:  2002-01-01       Impact factor: 3.857

2.  SPSB1, a Novel Negative Regulator of the Transforming Growth Factor-β Signaling Pathway Targeting the Type II Receptor.

Authors:  Sheng Liu; Thao Nheu; Rodney Luwor; Sandra E Nicholson; Hong-Jian Zhu
Journal:  J Biol Chem       Date:  2015-06-01       Impact factor: 5.157

Review 3.  Understanding cytokine and growth factor receptor activation mechanisms.

Authors:  Mariya Atanasova; Adrian Whitty
Journal:  Crit Rev Biochem Mol Biol       Date:  2012-10-09       Impact factor: 8.250

4.  Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.

Authors:  Kaye L Stenvers; Melinda L Tursky; Kenneth W Harder; Nicole Kountouri; Supavadee Amatayakul-Chantler; Dianne Grail; Clayton Small; Robert A Weinberg; Andrew M Sizeland; Hong-Jian Zhu
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  TGF-beta receptor levels regulate the specificity of signaling pathway activation and biological effects of TGF-beta.

Authors:  Andres Rojas; Malla Padidam; Dean Cress; William M Grady
Journal:  Biochim Biophys Acta       Date:  2009-02-12

6.  Schistosoma mansoni TGF-beta receptor II: role in host ligand-induced regulation of a schistosome target gene.

Authors:  Ahmed Osman; Edward G Niles; Sergio Verjovski-Almeida; Philip T LoVerde
Journal:  PLoS Pathog       Date:  2006-06-16       Impact factor: 6.823

7.  Ras enhances TGF-β signaling by decreasing cellular protein levels of its type II receptor negative regulator SPSB1.

Authors:  Sheng Liu; Josephine Iaria; Richard J Simpson; Hong-Jian Zhu
Journal:  Cell Commun Signal       Date:  2018-03-13       Impact factor: 5.712

8.  Myokine mediated muscle-kidney crosstalk suppresses metabolic reprogramming and fibrosis in damaged kidneys.

Authors:  Hui Peng; Qianqian Wang; Tanqi Lou; Jun Qin; Sungyun Jung; Vivekananda Shetty; Feng Li; Yanlin Wang; Xin-Hua Feng; William E Mitch; Brett H Graham; Zhaoyong Hu
Journal:  Nat Commun       Date:  2017-11-14       Impact factor: 14.919

9.  Estradiol Upregulates the Expression of the TGF-β Receptors ALK5 and BMPR2 during the Gonadal Development of Schizothorax prenanti.

Authors:  Taiming Yan; Songpei Zhang; Yueping Cai; Zhijun Ma; Jiayang He; Qian Zhang; Faqiang Deng; Lijuan Ye; Hongjun Chen; Liang He; Jie Luo; Deying Yang; Zhi He
Journal:  Animals (Basel)       Date:  2021-05-11       Impact factor: 2.752

Review 10.  On-Target Anti-TGF-β Therapies Are Not Succeeding in Clinical Cancer Treatments: What Are Remaining Challenges?

Authors:  Adilson Fonseca Teixeira; Peter Ten Dijke; Hong-Jian Zhu
Journal:  Front Cell Dev Biol       Date:  2020-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.